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Abstract Previously, several studies have demonstrated that
autophosphorylation of the C-terminal tyrosine residues (Tyr1316
and Tyr1322) affects the signaling properties of the insulin
receptor in vivo. To assess the biochemical consequences of the
C-terminal phosphorylation in vitro, we have constructed,
purified and characterized 45 kDa soluble insulin receptor kinase
domains (IRKD), either with (IRKD) or without (IRKD-Y2F)
the two C-terminal tyrosine phosphorylation sites, respectively.
According to HPLC phosphopeptide mapping, autophosphoryla-
tion of the three tyrosines in the activation loop of the IRKD-
Y2F kinase (Tyr1146, Tyr1150, and Tyr1151) was not affected by
the mutation. In addition, the Y2F mutation did not significantly
change the Km values for exogenous substrates. However, the
mutation in IRKD-Y2F resulted in a decrease in the maximum
velocities of the phosphotransferase reaction in substrate
phosphorylation reactions. Moreover, the exchange of the
tyrosines in IRKD-Y2F led to an increase in the apparent Km
values for ATP, suggesting a cross-talk of the C-terminus and
the catalytic domain of the enzyme. In addition, as judged by size
exclusion chromatography, conformational changes of the
enzyme following autophosphorylation were abolished by the
removal of the two C-terminal tyrosines. These data suggest a
regulatory role of the two C-terminal phosphorylation sites in the
phosphotransferase activity of the insulin receptor. ß 2000
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1. Introduction
The cytosolic tyrosine kinase domains of the insulin recep-
tor (IR) are activated upon binding of insulin to the extra-
cellular domains of the receptor [1,2]. This insulin-mediated
receptor kinase activation leads to receptor autophosphoryla-
tion on multiple tyrosine residues in the juxtamembrane do-
main (Tyr960), the catalytic domain (Tyr1146, Tyr1150, and
Tyr1151), and the C-terminal domain (Tyr1316, Tyr1322). The
autophosphorylation enhances the ability of the receptor to
catalyze the phosphorylation of exogenous substrates [3^7].
The C-terminal domain seems to play a distinct role in signal
transmission and signal speci¢city of the receptor. In addition
to regulatory sequences [8^10], the C-terminus contains two
tyrosine autophosphorylation sites, Tyr1316 and Tyr1322. C-ter-
minal deletion mutants of the IR have been shown to be poor
mediators of the metabolic e¡ects of insulin, without a¡ecting
the mitogenic signalling [11,12]. In contrast, mutant receptors
in which the two C-terminal tyrosine autophosphorylation
sites have been replaced by phenylalanines, stimulated mito-
genic e¡ects more e⁄ciently than wild-type receptors, how-
ever, without a¡ecting the metabolic signalling [13^15]. Evi-
dently, the C-terminal tail of the IR is involved in the
biological signalling of the receptor. However, the molecular
basis of this e¡ect is poorly understood.
To analyze whether the C-terminal tyrosine phosphoryla-
tion has an in£uence on the catalytic properties of the IR
kinase domain (IRKD), we have constructed a kinase mutant,
in which the two tyrosine residues (Tyr1316 and Tyr1322) were
replaced by phenylalanine (IRKD-Y2F). In the present study,
we have compared the enzymatic properties of the mutant
kinase with the wild-type enzyme IRKD, a widely used model
for the IR [16^21]. Our data indicate that the phosphorylation
of the C-terminal tyrosine residues appears to be play a role in
¢ne-tuning of the kinase activity.
2. Materials and methods
[Q-32P]ATP (6000 Ci/mmol) was obtained from Amersham. Restric-
tion endonucleases were from MBI Fermentas, Pfu polymerase was
from Stratagene, ATP was from Boehringer Mannheim. Cell culture
reagents were from Life Technologies Inc.; poly-L-lysine (Mr 15000^
30000) and poly(Glu:Tyr)4:1 were from Serva; antibodies (K-phospho-
tyrosine and GKR-AP) were from Boehringer Mannheim. Other re-
agents were obtained from common commercial sources.
2.1. Construction and expression of IRKD-Y2F and IRKD
IRKD-Y2F: The amino acids Tyr1316 and Tyr1322 were substituted
by phenylalanine by site-directed mutagenesis of the cDNA using
pUC-IRKD as template [21]. Two mutagenesis primer were con-
structed (5P-CAAGCGGAGCTTCGAGGAACACATTCCTTTCA-
CACACATG-3P ; 2: 5P-CATGTGTGTGAAAGGTATGTGTTCC-
TCGAAGCTCCGCTTG-3P), which, in addition to the amino acid
substitution, created a XmnI site in the IR cDNA. The mutagenesis
reaction was performed with the Quik-change site-directed mutagen-
esis kit according to the manufacturer’s instructions (Stratagene). The
region of the mutation was sequenced to ensure that no other muta-
tion had occurred. Construction of pVL1393-IRKD-Y2F was per-
formed as described for IRKD [21]. Spodoptera frugiperda (Sf9) cells
were cotransfected with Autographa californica nuclear polyhedrosis
virus (AcNPV) DNA and transfer vectors using the BaculoGold sys-
tem (Pharmingen) according to the manufacturer’s instructions. Re-
combinant viruses were isolated by performing plaque assays [22].
2.2. Puri¢cation of IRKD and IRKD-Y2F
Puri¢cation of the soluble kinases was accomplished by sequential
chromatography using MonoQ and phenyl^Sepharose (Pharmacia) as
described previously [21].
2.3. Construction and puri¢cation of GST-CT and GST-Ex20
For substrate phosphorylation reactions, two IR-derived GST fu-
sion proteins were constructed by polymerase chain reactions (PCR),
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and expressed in Escherichia coli. GST-CT contains the C-terminal
domain if the IR (Asn1249^Ser1343), includes the two C-terminal tyro-
sine residues Tyr1316 and Tyr1322. GST-Ex20 is derived from IR exon-
20, containing the three tyrosine phosphorylation sites of the catalytic
domain (Tyr1146, Tyr1150, Tyr1151). The PCR-ampli¢ed cDNA frag-
ments were gel-isolated and subcloned into the BamHI^EcoRI sites
of the expression vector pGEX 3X (Pharmacia). Expression and pu-
ri¢cation of GST fusion proteins was performed according to the
manufacturer’s instructions (Pharmacia).
2.4. Size exclusion chromatography
50 Wg of puri¢ed kinase was subjected to fast protein liquid chro-
matography on a Superose 12 column (Amersham Pharmacia Bio-
tech) at a £ow rate of 0.1 ml min31 in 50 mM Tris^HCl bu¡er, pH
7.5, containing 0.1 M NaCl, 1 mM dithiothreitol. Elution was moni-
tored by UV absorption at 280 nm. The column was calibrated with
standard proteins (Sigma) of known molecular mass: ferritin (440
kDa), aldolase (158 kDa), bovine serum albumin (67 kDa), ovalbumin
(43 kDa), chymotrypsin (25 kDa) and ribonuclease A (13.7 kDa).
2.5. Phosphorylation reactions
All phosphorylation reactions were carried out at room temperature
(22‡C). The reaction mixtures contained 50 mM Tris^HCl, pH 7.5,
5 mM MgCl2, 5 mM MnCl2, 250 WM [Q32P]ATP and 1 WM poly-L-
lysine. For substrate phosphorylation reactions, the kinases were pre-
phosphorylated for 5 min. Phosphorylated proteins were separated by
SDS^PAGE, localized by autoradiography and the radioactivity of
the excised bands was determined by measurement of Cerenkov radi-
ation in a Beckman scintillation counter. Substrate phosphorylations
with poly(Glu:Tyr)4:1 (1 mg ml31) were carried out using the phos-
phocellulose paper assay [23].
2.6. Phosphoamino acid analysis and phosphopeptide mapping
Tryptic digestion of the autophosphorylated kinases was performed
as described [24]. The recovery of 32P typically exceeded 90%. Tryptic
phosphopeptides were lyophilized in a Speed-Vac, hydrolyzed in 250
Wl of 6 N HCl at 110‡C for 2 h, washed twice with water and dried.
Two-dimensional phosphoamino acid analysis was performed by elec-
trophoresis [25]. Quantitation of phosphoamino acids was achieved by
using a phosphorimager (Bio-Rad Imaging System). HPLC-phospho-
peptide mapping was performed as described [21].
2.7. Other procedures
S. frugiperda (Sf9) cells were maintained as described [22]. Protein
concentrations were determined by a modi¢ed method of Bradford
[26]. SDS^PAGE was performed according to Laemmli [27]. Staining
of SDS^PAGEs was carried out by a modi¢ed Coomassie staining
procedure [28].
3. Results and discussion
Several studies have demonstrated that autophosphoryla-
tion of the C-terminal tyrosine residues (Tyr1316 and Tyr1322)
modulates the signaling properties of the IR in vivo [11^15].
However, it was unclear whether phosphorylation of the C-
terminal tyrosines a¡ects the physicochemical and catalytic
properties of the IR in vitro. Therefore, we have utilized the
baculovirus expression system [22] to overexpress and purify
the 45 kDa soluble IRKD, and in addition, a mutant IRKD
in which both C-terminal tyrosine residues Tyr1316 and
Tyr1322, have been replaced by phenylalanine (IRKD-Y2F).
Both soluble kinases were expressed at similar levels and sub-
sequently puri¢ed to s 95% homogeneity (Fig. 1; see Section
2).
In order to characterize the puri¢ed kinases, we have car-
ried out autophosphorylation reactions. For the wild-type
IRKD, phosphate incorporation after 30 min was 4.4 þ 0.2
mol phosphate per mol protein. Using our experimental con-
ditions (see Section 2), t1=2 for this reaction was 0.5 min and
the initial velocity was 161 nmol min31 mg31 (Fig. 2A). In
contrast, autophosphorylation of IRKD-Y2F resulted in a
maximum phosphate incorporation of only 2.9 þ 0.1 mol
phosphate/mol protein with an initial velocity of 88 nmol
Fig. 1. Puri¢cation of IRKD and IRKD-Y2F. A: SDS^PAGE of a
representative puri¢cation of IRKD. The recombinant kinase was
puri¢ed by anion exchange chromatography and hydrophobic inter-
action chromatography. After SDS^PAGE, the proteins were
stained with Coomassie blue. Lanes: 1, cell lysate; 2, after anion ex-
change chromatography; 3, after hydrophobic interaction chroma-
tography. B: Comparison of the puri¢cation states of IRKD (lane
1) and IRKD-Y2F (lane 2).
Fig. 2. Time course of the autophosphorylation of IRKD and
IRKD-Y2F, and phosphoamino acid analysis. A: Puri¢ed IRKD
(squares) and IRKD-Y2F (circles) were phosphorylated using stan-
dard conditions (see Section 2). At the indicated time points, ali-
quots were removed and assayed for incorporated phosphate (closed
symbols) and serine phosphate content (open symbols). B: Two-di-
mensional phosphoamino acid analysis of IRKD and IRKD-Y2F
after 30 min reaction time.
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min31 mg31. Thus, as expected, the C-terminal mutation in
the kinase results in a reduction of maximum phosphate in-
corporation. However, compared to the wild-type enzyme, the
half-time of the autophosphorylation reaction is unchanged.
We have shown previously that autophosphorylation of the
IRKD in vitro results in the phosphorylation of two serine
residues (Ser1275 and Ser1309) in the C-terminal domain of the
kinase [21]. As shown in Fig. 2, serine autophosphorylation
of IRKD and IRKD-Y2 exhibited similar time courses
(t1=2W5 min; initial velocity = 3.3 þ 0.2 nmol min31 mg31),
resulting in a maximum serine phosphorylation of W1 mol
phosphoserine per mol kinase, respectively. However, it
should be noted that phosphoserine and phosphotyrosine
may exhibit di¡erent stabilities during acid hydrolysis of phos-
phopeptides [29]. Thus, the observed dual kinase activity of
the IRKD is not correlated to the phosphorylation of the C-
terminal tyrosine residues, Tyr1316 and Tyr1322.
In a previous study, we have identi¢ed the major autophos-
phorylation sites of the soluble IRKD and the human IR by
HPLC phosphopeptide mapping and chemical sequencing of
tryptic phosphopeptides, respectively [21]. To test whether the
mutation of the two phosphorylation sites in the C-terminus
a¡ects the autophosphorylation of the tyrosine residues in the
catalytic domain, we have performed comparative HPLC
phosphopeptide mapping of the two autophosphorylated ki-
nases.
As shown in Fig. 3, the peak containing the phosphorylated
C-terminal tyrosine residues of the IRKD (Tyr1316, Tyr1322,
CT-YY) was completely absent in the corresponding HPLC
pro¢le of the IRKD-Y2F mutant. Also, as expected, the
amount of phosphoserine containing peptides, corresponding
to Ser1275 and Ser1309 was similar for both wild-type and
IRKD-Y2F mutant. Most importantly, the peak correspond-
ing to the tris-phosphorylated catalytic loop of the kinase
(Tyr1146, Tyr1150, Tyr1151, CD-YYY) appeared to be similar
for both wild-type IRKD and mutant IRKD-Y2F. As indi-
cated in Fig. 3, the total eluted radioactivity of the fractions
containing CD-YYY was the same for both wild-type and
IRKD-Y2F. Thus, these data demonstrate that the mutation
of the two C-terminal autophosphorylation sites has neither
an e¡ect on the phosphorylation of the three tyrosines in the
activation loop, nor on the phosphorylation of the serine res-
idues in the C-terminus of IR kinase.
We next examined whether the mutation of the C-terminal
tyrosine residues a¡ects the phosphorylation of exogenous
substrates. As substrates for kinetic studies we used GST fu-
sion proteins containing the major tyrosine phosphorylation
sites of the IRKD. GST-Ex20 comprises human IR residues
Phe1139^Asp1179, and contains the three tyrosine autophos-
phorylation sites (Tyr1146, Tyr1150 and Tyr1151) of the activa-
tion loop of the kinase. GST-CT contains IR residues
Asn1249^Ser1343, including the two C-terminal tyrosine auto-
phosphorylation sites Tyr1316 and Tyr1322. The phosphoryla-
tion reactions were performed in presence of poly-L-lysine (see
Section 2), using the pre-phosphorylated enzymes to enable
maximum activity of the kinases [30,31]. The resulting kinetic
data were ¢tted according to the Michaelis^Menten model. As
indicated by the observed Km values (Fig. 4A,B and Table 1),
both fusion proteins served as high a⁄nity substrates for the
Fig. 3. Phosphopeptide mapping of IRKD and IRKD-Y2F after 30
min reaction time. IRKD and IRKD-Y2F were phosphorylated us-
ing standard conditions (see Section 2) and separated by SDS^
PAGE. The proteins were digested with trypsin and phosphopepti-
des were separated by HPLC anion exchange chromatography.
Fig. 4. Kinetic parameters of IRKD and IRKD-Y2F. For substrate phosphorylation reactions the enzymes were pre-phosphorylated for 15 min
in the presence of 50 mM Tris^HCl, pH 7.5, 250 WM [Q-32P]ATP, 1 WM poly-L-lysine. Substrate proteins were added at the indicated concentra-
tions and incubated further for 0.5 min. After separation by SDS^PAGE, the amount of incorporated phosphates was determined (see Section
2), and the resulting data were ¢tted according to the Michaelis^Menten model. Data are the means þ S.E.M. of three separate experiments.
A: Lineweaver^Burk plot of GST-CT substrate phosphorylation. B: Lineweaver^Burk plot of GST-Ex20 substrate phosphorylation. C: IRKD
and IRKD-Y2F were phosphorylated for 0.5 min with varying ATP concentrations, as indicated. After separation by SDS^PAGE, the amount
of incorporated phosphates was determined (see Section 2), and the resulting data were ¢tted according to the Michaelis^Menten model. Data
are the means þ S.E.M. of three separate experiments.
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IRKD. Interestingly, in previous studies the Km values for
short synthetic peptides derived from the autophosphorylation
sites of the human IR were reported to be in the upper micro-
to millimolar range [32,33]. Accordingly, the W5^10-fold low-
er Km values for the GST fusion proteins used in the present
study indicate that optimal substrate recognition of the en-
zyme requires an interaction with additional regions in the
fusion proteins which were not present in the short synthetic
peptides that have been used in previous studies [32,33].
The observed kinetic parameters, Km and Vmax, for GST-
Ex20 were only slightly di¡erent for the wild-type and the
mutant IRKD (Table 1). Surprisingly, compared to the
wild-type kinase, IRKD-Y2F showed a 4-fold decrease in
the maximum velocity when using GST-CT as a substrate,
whereas the observed Km values for GST-CT remained un-
changed (Fig. 4A,B and Table 1). Thus, the mutation of the
C-terminal tyrosine residues in the kinase alters the transfer-
ase activity of the receptor kinase towards GST-CT in a non-
competitive fashion. Similarly, the speci¢c phosphotransferase
activity of IRKD-Y2F using Poly(Glu:Tyr)4:1 as a substrate
was also reduced (182 nmol min31 mg31 for IRKD; 100 nmol
min31 mg31 for IRKD-Y2F).
Since the latter experiments were all carried out in the pres-
ence of poly-L-lysine, which is known to enhance the kinase
activity of IRKD [7,17], we have carried out additional phos-
phorylation reactions with GST-CT in the absence of the
basic polycation. Compared to the poly-L-lysine-stimulated
reaction, the Vmax values for both, IRKD and IRKD-Y2F,
were about equally reduced (W20-fold; IRKD: 5 nmol min31
mg31 ; IRKD-Y2F: 1.3 nmol min31 mg31). Likewise, in the
absence of poly-L-lysine the observed Km values for GST-CT
were increased W2^3-fold for both, IRKD (20 WM) and
IRKD-Y2F (11 WM), respectively. As a result, the W4-fold
reduction in the Vmax value for IRKD-Y2F was observed even
in the absence of poly-L-lysine.
In fact, these data suggest that the mutation of the two C-
terminal autophosphorylation sites in the kinase might inter-
fere with the integrity of the active site of the enzyme. There-
fore, we have determined the apparent kinetic parameters for
ATP in autophosphorylation reactions. As shown in Fig. 4C
and Table 1, the observed values for Vmax and Km for IRKD
agreed reasonable well with previous observations [17,34^36].
In contrast, IRKD-Y2F showed a signi¢cant increase in the
Km value whereas Vmax was decreased. Thus, the mutation of
the C-terminal phosphorylation sites of the kinase has a direct
in£uence on the apparent a⁄nity of ATP and furthermore,
causes a decrease in the maximum velocity of the reaction.
Interestingly, several reports have demonstrated that deletion
of the C-terminal domain of the IR kinase a¡ects the a⁄nities
for substrates and the maximum velocities (Vmax) of the ki-
nase reaction in vitro [34,37]. Similar results were obtained
using anti-peptide antibodies against regulatory motifs in the
C-terminal domain [9,10]. Notably, a recent study in our lab-
oratory revealed that a single point mutation in the catalytic
domain of the IRKD (Tyr1151CPhe) led to a decreased auto-
phosphorylation of the C-terminal serine residues, without
a¡ecting the autophosphorylation of the two tyrosines,
Tyr1316 and Tyr1322 [38].
To evaluate any interaction between the C-terminal phos-
photyrosines and the active site of the kinase we have per-
formed gel ¢ltration chromatography experiments to detect
phosphorylation-induced changes in the overall shape of the
kinase (Fig. 5). Both, IRKD and IRKD-Y2F were subjected
onto a Superose 12 column either in the phosphorylated or
non-phosphorylated state, respectively, and the elution of the
proteins was measured by UV absorption at 280 nm. The
non-phosphorylated IRKD migrated with an apparent molec-
ular mass of V60 kDa. However, after autophosphorylation
the apparent molecular mass of the IRKD shifted to V100
kDa. Since the gel ¢ltration experiments were carried out in
the presence of 1 M NaCl (see Section 2), these alteration
could rather be explained by changes in the conformation of
the molecule, than by the formation of stable kinase dimers.
This is in agreement with the observation that phosphorylated
and non-phosphorylated IRKD migrated with the same ap-
Table 1
Kinetic parameters of IRKD and IRKD-Y2F
IRKD IRKD-Y2F
Km (WM) Vmax (nmol min31 mg31) Km (WM) Vmax (nmol min31 mg31)
GST-CT 6.1 þ 0,5 117.0 þ 3,6 7.4 þ 2.3 26.3 þ 1.9
GST-Ex20 2.9 þ 0,6 53.9 þ 2.1 4.7 þ 0.9 37.7 þ 7.9
ATP 135 þ 28 230 þ 23 299 þ 33 106 þ 6
Fig. 5. Size exclusion chromatography. Puri¢ed IRKD (upper pro-
¢le) or IRKD-Y2F (lower pro¢le) were incubated for 30 min with
50 mM Tris^HCl, pH 7.5, 250 WM [Q-32P]ATP in the presence
(closed symbols) or absence (open symbols) of 250 WM ATP, respec-
tively, and subjected to size exclusion chromatography. Elution was
monitored by UV absorption at 280 nm. The inset depicts the loga-
rithms of the molecular masses of the protein standards, plotted
against the respective elution fraction (protein standards: ferritin
(440 kDa), aldolase (158 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa), chymotrypsin (25 kDa) and ribonuclease A
(13,7 kDa)).
FEBS 23995 3-8-00
N. Tennagels et al./FEBS Letters 479 (2000) 67^7170
parent molecular mass in native polyacrylamide gel electro-
phoresis (data not shown). In contrast, either in its phosphor-
ylated or non-phosphorylated state, IRKD-Y2F eluted with
an apparent molecular mass of 60 kDa from the column. A
similar result was obtained for a soluble IR kinase, where 72
amino acids from the C-terminal domain were deleted (E.
Bergschneider, unpublished results). Evidently, autophosphor-
ylation of the C-terminal tyrosine residues, Tyr1316 and
Tyr1322, has a profound e¡ect on the Stoke’s radius of the
kinase molecule, thereby leading to signi¢cant changes in
the hydrodynamic properties of IRKD.
In summary, we have shown that mutation of the C-termi-
nal tyrosine autophosphorylation sites (Tyr1316 and Tyr1322) in
the IRKD apparently does not interfere with the activation of
the kinase as judged by the presence of the tris-phosphorylat-
ed catalytic loop in phosphopeptide maps of IRKD-Y2F.
However, the mutation led to a decrease in the Vmax-value
for the IRKD C-terminus in substrate phosphorylation reac-
tions, and, more importantly to a reduced apparent a⁄nity
for ATP. Lastly, we have presented evidence that autophos-
phorylation of the two C-terminal tyrosine residues, induces a
large increase in the Stoke’s radius of the kinase, indicating
conformational changes in the kinase upon phosphorylation
of Tyr1316 and Tyr1322.
Thus, we propose that phosphorylation of the C-terminal
tyrosine residues modulates the kinase activity by phosphor-
ylation-dependent interactions of the C-terminus with the cat-
alytic domain of the kinase. Unfortunately, due to the re-
ported £exibility of the IRKD C-terminus, no crystal
structure of the IR kinase containing the C-terminal domain
has been made available [40]. However, changes in the con-
formation of the IR induced by binding of a C-terminal do-
main to the kinase were also reported by others [39]. Interest-
ingly, Shoelson et al. demonstrated that substrate analogs,
containing phenylalanine instead of tyrosine, (i.e. pseudosub-
strate sequences) inhibited substrate phosphorylation of the
IR in a non-competitive fashion [41]. Most recently, it has
been reported that the C-terminal tail of protein kinase A
directly interacts with both peptide substrates and the ATP-
binding site of the kinase [42]. Hence, one might speculate
that the non-phosphorylated C-terminus in IRKD acts in an
autoinhibitory fashion by binding to the catalytic site, thereby
changing the overall shape of the molecule and modulating
the catalytic activity of the enzyme.
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